DCZ0415

CAS : 2242470-43-3

Ref. 3D-SPD47043

Informations sur le produit

• Nom: DCZ0415
• CAS: 2242470-43-3

Description

DCZ0415 is a histone deacetylase (HDAC) inhibitor. It is used for the treatment of cancer by inducing cell differentiation and inhibiting tumor growth. DCZ0415 has been shown to be effective in a number of animal models, including those with prostate cancer, breast cancer, and colon cancer. This drug has also been shown to be effective in treating malignant cancers in humans, such as lung and pancreatic cancers. DCZ0415 inhibits HDAC activity at the transcriptional level and has been shown to have anti-inflammatory effects.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 356.4 g/mol
• Formule: C₂₃H₂₀N₂O₂
• Degré de pureté: Min. 95%